VIOL Medical is a medical device company leading the global medical aesthetics market,
based on proprietary RF core technology and continuous R&D.
Innovation
VIOL Medical leads the future of medical aesthetics
through new technologies and differentiated solutions.
We expand new possibilities for beauty through relentless research and challenges.
Trust
Placing safety and expertise first,
we provide products and experiences that both healthcare professionals and customers can trust.
Trust is the most important standard for VIOL Medical.
Excellence
Through precise technology and meticulous attention to detail,
we deliver the highest quality and premium experiences.
We believe that small differences create the best results.
Sustainability
VIOL Medical pursues beauty that endures healthily over time,
not just temporary change.
We consider the balance between technology, beauty, and life together.
History
VIOL Medical's innovation goes beyond technology, reaching people and the future.
- Launch of HIGU's Duotight Product in Korea
- Company Name Change to VIOL Medical Co., Ltd.
- Sylfirm X becomes the first micro-needling RF device to receive KFDA approval for melasma treatment
- Cellinew obtains medical device approval in Indonesia
- Sylfirm X receives TFDA approval in Taiwan
- Launch of HIFU device DUOTITE
- Launch of monopolar RF device CELLINEW
- Received the Trade Day Export Tower Award of $30 Million
- CELLINEW obtains FDA clearance in the United States
- Launched Sylfirm X XB-49 Pin Tip
- Launched Scarlet S in China
- DUOTITE obtains KFDA Medical Device Manufacturing License
- Sylfirm X obtains Anvisa approval in Brazil
- Received the Trade Day Export Tower Award of $20 Million
- Supply agreement for Scarlet S in China
- Exclusive agreement for Sylfirm X in China
- Sylfirm X 3 Tips receives FDA approval
- Smartlux Mini receives FDA approval
- Received the Trade Day Export Tower Award of $10 Million
- Medical device registration in Mexico
- Medical device registration in Indonesia
- Expansion of headquarters production facilities
- Distributor agreements signed
- Supply agreement for Japan
- Listed on KOSDAQ
- Sylfirm X ranked No.1 in Korean brand preference
- Received the Trade Day Export Tower Award of $7 Million
- Scarlet selected as a world-class product
- Launched Sylfirm X
- Sylfirm X received FDA & CE approval
- Selected as a "Designated Startup" by the Korean government
- Distributor agreements signed in Canada and the United States
- Received the Trade Day Export Tower Award of $5 Million
- Selected as an outstanding job creation company in Gyeonggi-do
- Scarlet received FDA approval
- Selected as a promising SME in Gyeonggi-do
- Obtained Korean patent for vascular treatment device
- Obtained Japanese patent for endoscope tube device
- "NA EFFECT" patent obtained in 6 countries
- Certified as a technology-innovation SME
- Launched Sylfirm
- Scarlet received CFDA approval
- Scarlet S received CE & MDD approval
- Launched new Scarlet S
- PCT application filed in 13 countries
- Obtained impedance control patent
- Obtained 2 patents for skin care technology
- Obtained patent for endoscope tube device
- Selected as a promising export-oriented SME
- Obtained "NA EFFECT" patent
- Obtained skin care technology patent
- Established R&D center
- Obtained patent for electric skin care device
- Scarlet received CE & MDD approval
- Obtained KGMP certificate
- Started manufacturing Scarlet
- Research and development of HMGF
- Founded VIOL Co., Ltd.
GLOBAL NETWORK
VIOL Medical exports its products to over 70 countries worldwide, spanning North America, Europe, Asia, the Middle East, and Oceania,
strengthening its presence in the global medical device market.
-
Americas
- Canada
- United States
- Argentina
- Brazil
- Costa Rica
- Colombia
- Chile
- Dominican Republic
- Guatemala
- Mexico
- Panama
- Uruguay
-
Europe
- Greece
- Netherlands
- Germany
- Russia
- Romania
- Moldova
- Belarus
- Belgium
- Bulgaria
- Armenia
- Ireland
- Albania
- United Kingdom
- Poland
- Portugal
- France
- Türkiye
- Czech Republic
- Hungary
-
Middle East
- Lebanon
- Bahrain
- Iraq
- Iran
- Oman
- Jordan
- Syria
- Qatar
- Kuwait
- Saudi Arabia
- United Arab Emirates
-
Asia
- Taiwan
- Malaysia
- Bangladesh
- Vietnam
- Singapore
- India
- Indonesia
- Japan
- China
- Kazakhstan
- Kyrgyzstan
- Pakistan
- Thailand
- Hong Kong
-
Oceania
- New Zealand
- Australia
-
Africa
- Morocco
- Algeria
- Egypt
- Tunisia